UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002310
Receipt number R000002816
Scientific Title Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.
Date of disclosure of the study information 2009/08/31
Last modified on 2014/03/27 18:02:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.

Acronym

Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients. (GBCRG-2surg-01)

Scientific Title

Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.

Scientific Title:Acronym

Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients. (GBCRG-2surg-01)

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Endocrine surgery Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of adjuvant chemotherapy combined with docetaxel and cyclophosphamide for breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Safety
completion rate

Key secondary outcomes

Disease free survival
Overall survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

four cycles of therapy, administered every 3 weeks.
Docetaxel (75 mg/m2) and Cyclophosphamide (600 mg/m2) are administered by intravenous infusion on day 1 in eacn cycle.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

1) Histologically diagnosed breast cancer without lymph node metastasis or with three and under lymph node metastasis.
2)Age 20 to 70 years
3)ECOG PS 0 to 2
4)Previous endocrine therapy or chemotherapy for breast cancer.
5)Required baseline laboratory parameters
6)Without severe complications,ischemia attack, uncontrolled congestive heart failure
7)Written informed consent

Key exclusion criteria

1)Patients who received previous endocrine therapy or chemotherapy
2)Severe drug allergic history
3)Inflammatory breast cancer
4)Bilateral breast cancer in same time
5)Severe complications
6)Active double cancer
7)Inflammation with fever up
8)Neurological problem
9)Pleural effusion or pericardial effusion
10)Symptomatic brain metastasis
11)Pregnancy
12)Severe edema
13)Interstitial lung disease, pulmonary fibrosis
14)Psychiatric disease
15)Doctors decision for excluion
16)Low risk in St. Gallen Conferences 2007
17)16 weeks or more after operation

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nana Rokutanda

Organization

Gunma University Graduate School of Medicine

Division name

Thoracic Visceral Organ Surgery

Zip code


Address

3-39-15 Showa-machi, Maebashi-city, Gunma, 371-8511, Japan

TEL

027-220-8245

Email

nana.rokutanda@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Nana Rokutanda

Organization

Gunma Breast Cancer Research Group 2 surgery (GBCRG-2surg) 01

Division name

Secretariat Division (Department of Thoracic Visceral Organ Surgery , Gunma University Graduate Scho

Zip code


Address

3-39-15 Showa-machi, Maebashi-city, Gunma, 371-8511, Japan

TEL

027-220-8245

Homepage URL


Email

nana.rokutanda@gmail.com


Sponsor or person

Institute

Gunma Breast Cancer Research Group 2 surgery

Institute

Department

Personal name



Funding Source

Organization

Department of Thoracic Visceral Organ Surgery ,
Gunma University Graduate Schol of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 06 Month 24 Day

Date of IRB


Anticipated trial start date

2009 Year 07 Month 01 Day

Last follow-up date

2016 Year 12 Month 01 Day

Date of closure to data entry

2016 Year 12 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 08 Month 09 Day

Last modified on

2014 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002816


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name